Acomhal Research, Inc.

Roanoke, VA

UEI
QCZ3GLF8WNP5
CAGE
7LJG5
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
709 S Jefferson St, Roanoke, VA 24016, USA
Website
acomhal.com
Founded
2016
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Inhibition of breast cancer cell metastases using a CONNEXIN43 mimetic peptide R41CA250874 National Cancer Institute (NIH) $399,878
Therapeutic disruption of CONNEXIN43-mediated microtubule regulation to target glioblastoma cancer stem cells R41CA217503 National Cancer Institute (NIH) $224,994

Quick answers

Is Acomhal Research, Inc. registered in SAM.gov?

Yes. Acomhal Research, Inc.'s SAM.gov registration is active through August 19, 2027.

What is Acomhal Research, Inc.'s most recent federal award?

Acomhal Research, Inc.'s most recent federal grant award is Inhibition of breast cancer cell metastases using a CONNEXIN43 mimetic peptide (R41CA250874), from National Cancer Institute (NIH), on July 1, 2020.

On GovTribe

See Acomhal Research, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login